News/ News/ Oncology Belgium’s eTheRNA gets EU grant to develop mRNA cancer vaccines Richard Staines BioNTech, cancer vaccine, eTheRNA, Pfizer, vaccine 0 Comment Belgian immunotherapy firm eTheRNA has received a €6.9 million grant from the European Commission to accelerate clinical development Share X Belgium’s eTheRNA gets EU grant to develop mRNA cancer vaccines https://pharmaphorum.com/news/belgiums-etherna-gets-eu-grant-to-develop-mrna-cancer-vaccines/
BioNTech, cancer vaccine, eTheRNA, Pfizer, vaccine
0 Comment
